KAYLA COWDEN: Open Payments
NPI 1801412770 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 14 payments from 7 companies in 2025. Trend: 2023 $445 · 2024 $235 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $264 |
| Edwards Lifesciences Corporation | 1 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| PFIZER INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
| Amgen Inc. | 1 | $16 |
Products named: SAPIEN 3 Ultra RESILIA, LEQVIO, ELIQUIS, CAMZYOS, WATCHMAN FLX, Repatha, ENTRESTO.
Industry payments across TX — which companies pay providers there.
